0001950047-23-001365.txt : 20230607 0001950047-23-001365.hdr.sgml : 20230607 20230607161009 ACCESSION NUMBER: 0001950047-23-001365 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230607 DATE AS OF CHANGE: 20230607 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 23999071 BUSINESS ADDRESS: STREET 1: 499 ILLINOIS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 499 ILLINOIS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Pang Phillip CENTRAL INDEX KEY: 0001787370 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O VIR BIOTECHNOLOGY, INC. STREET 2: 499 ILLINOIS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 144 1 primary_doc.xml 144 0001787370 XXXXXXXX LIVE 0001706431 VIR BIOTECHNOLOGY INC 001-39083 499 Illinois Street San Francisco CA 94158 4159064324 PHILLIP PANG Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

5000 130200.00 133976538 06/07/2023 NASDAQ Common 06/07/2023 Exercise of Stock Options Issuer N 5000 06/07/2023 Cash Y 06/07/2023 03/08/2023 /s/ Phillip Pang